MedPath

SANDOZ FINASTERIDE

SANDOZ FINASTERIDE

Approved
DIN Number

02322579

Drug Class

Human

Market Date

Feb 1, 2010

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02322579
AIG Number0124110001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04CB01 FINASTERIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FINASTERIDEActive
Strength: 5 MG
Monograph: FINASTERIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.